{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:07:15Z","timestamp":1780423635874,"version":"3.54.1"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Tumor hypoxia is biologically important in breast cancer, but its prognostic value may be distorted by intrinsic molecular subtype composition. This study evaluated whether hypoxia-related prognosis was subtype-dependent and whether hypoxia was associated with genome-wide copy-number alteration (CNA) burden. Transcriptome-derived hypoxia scores, CNA burden, and overall survival data were analyzed from TCGA and METABRIC. Survival differences between hypoxia groups were assessed using Kaplan\u2013Meier analysis and log-rank tests. Multivariable Cox models were used to evaluate hypoxia-related prognosis after adjustment for subtype and eligible clinical covariates. Proportional hazards diagnostics and Weibull accelerated failure time models were further applied to address potential model-assumption violations. In TCGA, the cohort-wide survival association was no longer evident after adjustment for subtype and clinical covariates. The clearest subtype-specific signal was observed in Luminal B tumors. Within this subtype, low hypoxia was associated with better survival after adjustment for age, stage, and CNA burden. In METABRIC, high hypoxia remained associated with poorer survival in Weibull accelerated failure time models. Higher hypoxia was also consistently associated with greater CNA burden across both cohorts. These findings support subtype-aware interpretation of hypoxia biomarkers and suggest a reproducible link between hypoxia and genomic instability in breast cancer.<\/jats:p>","DOI":"10.1371\/journal.pone.0350829","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:33:46Z","timestamp":1780421626000},"page":"e0350829","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor hypoxia is associated with global copy-number alteration burden and subtype-dependent overall survival in breast cancer: Evidence from TCGA and METABRIC"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0894-0445","authenticated-orcid":true,"given":"Wenhan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"5","key":"pone.0350829.ref001","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"D Hanahan","year":"2011","journal-title":"Cell"},{"issue":"4","key":"pone.0350829.ref002","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"M H\u00f6ckel","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"pone.0350829.ref003","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia--a key regulatory factor in tumour growth","volume":"2","author":"AL Harris","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"pone.0350829.ref004","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"GL Semenza","year":"2012","journal-title":"Cell"},{"issue":"6","key":"pone.0350829.ref005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment","volume":"4","author":"JM Brown","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"pone.0350829.ref006","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2007.04.019","article-title":"Hypoxia-inducible factors, stem cells, and cancer","volume":"129","author":"B Keith","year":"2007","journal-title":"Cell"},{"issue":"6","key":"pone.0350829.ref007","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/cncr.11246","article-title":"Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma","volume":"97","author":"R Bos","year":"2003","journal-title":"Cancer"},{"issue":"3","key":"pone.0350829.ref008","article-title":"Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers","volume":"3","author":"J-T Chi","year":"2006","journal-title":"PLoS Med"},{"issue":"2","key":"pone.0350829.ref009","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/sj.bjc.6605450","article-title":"Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene","volume":"102","author":"FM Buffa","year":"2010","journal-title":"Br J Cancer"},{"issue":"6797","key":"pone.0350829.ref010","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"CM Perou","year":"2000","journal-title":"Nature"},{"issue":"19","key":"pone.0350829.ref011","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"T S\u00f8rlie","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"pone.0350829.ref012","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"JS Parker","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"pone.0350829.ref013","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2007-8-5-r76","article-title":"Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors","volume":"8","author":"JI Herschkowitz","year":"2007","journal-title":"Genome Biol"},{"issue":"9","key":"pone.0350829.ref014","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ng1861","article-title":"A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers","volume":"38","author":"SL Carter","year":"2006","journal-title":"Nat Genet"},{"issue":"10","key":"pone.0350829.ref015","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ng.2760","article-title":"Pan-cancer patterns of somatic copy number alteration","volume":"45","author":"TI Zack","year":"2013","journal-title":"Nat Genet"},{"issue":"19","key":"pone.0350829.ref016","doi-asserted-by":"crossref","first-page":"8504","DOI":"10.1128\/MCB.24.19.8504-8518.2004","article-title":"Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells","volume":"24","author":"RS Bindra","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"7418","key":"pone.0350829.ref017","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"issue":"7403","key":"pone.0350829.ref018","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"C Curtis","year":"2012","journal-title":"Nature"},{"key":"pone.0350829.ref019","doi-asserted-by":"crossref","first-page":"11479","DOI":"10.1038\/ncomms11479","article-title":"The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes","volume":"7","author":"B Pereira","year":"2016","journal-title":"Nat Commun"},{"issue":"5","key":"pone.0350829.ref020","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"E Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"269","key":"pone.0350829.ref021","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"J Gao","year":"2013","journal-title":"Sci Signal"},{"issue":"4","key":"pone.0350829.ref022","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"CH Mermel","year":"2011","journal-title":"Genome Biol"},{"issue":"282","key":"pone.0350829.ref023","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"EL Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"pone.0350829.ref024","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"N Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"issue":"2","key":"pone.0350829.ref025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression Models and Life-Tables","volume":"34","author":"DR Cox","year":"1972","journal-title":"J Royal Stat Soc Series B: Stat Methodol"},{"issue":"1","key":"pone.0350829.ref026","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"J Royal Stat Soc Series B: Stat Methodol"},{"issue":"6322","key":"pone.0350829.ref027","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf8399","article-title":"Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy","volume":"355","author":"T Davoli","year":"2017","journal-title":"Science"},{"issue":"3","key":"pone.0350829.ref028","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","article-title":"Blinded by the light: the growing complexity of p53","volume":"137","author":"KH Vousden","year":"2009","journal-title":"Cell"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350829","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:33:51Z","timestamp":1780421631000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350829"}},"subtitle":[],"editor":[{"given":"UDAYAN","family":"BHATTACHARYA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0350829","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]}}}